Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 9, 2017
Issued Date -
N/A
app pub date -
Jul 10, 2009
filing date -
Jul 10, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to a method for the treatment of an inflammatory disorder in a mammal, said method comprising administering to a mammal in need of such treatment a therapeutically effective amount of (R)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane ((R)-DOI) in a pharmaceutically acceptable carrier or salt thereof, wherein said inflammatory disorder is associated with a disease selected from asthma, rheumatoid arthritis, irritable bowel syndrome, and Crohn's disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully